OC

Orion Capital Group, Inc.

North America, California, United States, Redwood City

Description

M&A Advisory and Investment Banking

Investor Profile

Orion Capital Group, Inc. has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Singapore.
  • Strong thematic focus on Biotechnology, Financial Services, FinTech.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • United States (50%)
  • Singapore (50%)

Industry Focus

  • Biotechnology
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Orion Capital Group, Inc. frequently co-invest with?

DH
North America, California, United States, Beverly Hills
Co-Investments: 1
C-Bridge Capital
North America, New York, United States, New York
Co-Investments: 1
Co-Investments: 1
Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
SC
North America, New York, United States, New York
Co-Investments: 1
FI
North America, Texas, United States, San Antonio
Co-Investments: 1
Credit Saison
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Global Founders Capital
Europe, Berlin, Germany, Berlin
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Ion Pacific
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1

What are some of recent deals done by Orion Capital Group, Inc.?

Chocolate Finance

Singapore, Central Region, Singapore

Chocolate Finance is a Sinagapore based fintech startup.

Financial ServicesFinTech
Series AAug 25, 2022
Amount Raised: $19,000,000
AffaMed Therapeutics

New City, New York, United States

AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.

Biotechnology
Series BMar 30, 2021
Amount Raised: $170,000,000

Find More Investors Like Orion Capital Group, Inc.

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Orion Capital Group, Inc. | Pipeseed